Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Squamous Cell Carcinoma

Explore clinical trials studying Head and Neck Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

354 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Squamous Cell Carcinoma trial results

Active, Not Recruiting

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT03983954

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenoma, +79 more
Locations
  • Shalby Hospital Ahmedabad, Gujarat, India
  • National Cancer Institute Jhajjar, Haryana, India
  • All India Institute of Medical Sciences New Delhi, India
  • PMCH (Pacific Medical College & Hospital) Udaipur, Rajasthan, India
View Trial Details
Active, Not Recruiting

A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

NCT05238883

Conditions
Adenocarcinoma, Adenoma, Bronchial Neoplasms, +57 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer

NCT03383094

Conditions
Cancer, Cancer of Head and Neck, Cancer, Advanced, +35 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • H. Lee Moffitt Cancer Center & Research Facility Tampa, Florida, United States
  • Washington University School of Medicine, Siteman Cancer Center St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

A Clinical Study of SI-B001 in Combination With Paclitaxel in the Treatment of Recurrent and Metastatic HNSCC

NCT05054439

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • The Second Affiliated Hospital of Guilin Medical University Guilin, Guangxi, China
  • The Affiliated Cancer Hospital of Guizhou Medical University Guiyang, Guizhou, China
  • Union Hospital Tongji Medical College， Huazhong University of Science and Technology Wuhan, Hubei, China
  • Hunan Cancer Hospital Changsha, Hunan, China
View Trial Details
Active, Not Recruiting

A Clinical Study to Evaluate the Efficacy and Safety of SI-B001 in the Treatment of Recurrent and Metastatic HNSCC

NCT05044897

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • The Second Affiliated Hospital of Guilin Medical University Guilin, Guangxi, China
  • The Affiliated Cancer Hospital of Guizhou Medical University Guiyang, Guizhou, China
  • Shanghai Oriental Hospital Shanghai, Shanghai Municipality, China
View Trial Details
Active, Not Recruiting

Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT06082167

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Exelixis Clinical Site #2 Fullerton, California, United States
  • Exelixis Clinical Site #1 Orange City, Florida, United States
  • Exelixis Clinical Site #163 Tampa, Florida, United States
  • Exelixis Clinical Site #123 Athens, Georgia, United States
View all 168 locations
View Trial Details

Related conditions